102226-40-4 Usage
General Description
2H-Pyrido[4,3-b]-1,4-oxazin-3(4H)-one(9CI) is a chemical compound recognized by its nine Carbon Index (9CI) identifier. There is currently limited information available about its properties, characteristics, or applications. As indicated by its chemical name, it falls within the class of compounds called oxazines, which are heterocyclic compounds containing an oxygen and a nitrogen atom in a six-membered ring. However, specific details about this particular compound, such as its physical and chemical properties, hazards, and safe handling practices, may require further scientific research and investigations. Also, its potential uses and industries where it could be applied remain unknown. Detailed and comprehensive studies would help uncover the compound's attributes and potential applications but it's not widely studied or recognized.
Check Digit Verification of cas no
The CAS Registry Mumber 102226-40-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,2,2 and 6 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 102226-40:
(8*1)+(7*0)+(6*2)+(5*2)+(4*2)+(3*6)+(2*4)+(1*0)=64
64 % 10 = 4
So 102226-40-4 is a valid CAS Registry Number.
102226-40-4Relevant articles and documents
METHOD FOR PREPARING HETEROCYCLIC DERIVATIVE COMPOUND, COMPOSITION CONTAINING SAME COMPOUND, AND HYDRATE OF SAME COMPOUND
-
Paragraph 0099, (2020/04/21)
The present invention relates to: a novel method for preparing a heterocyclic derivative compound of chemical formula I below; a novel intermediate compound used in the preparation method; a composition for treatment or prevention of hyperuricacidemia, gout, nephritis, chronic renal insufficiency, nephrolith, uremia, urolithiasis, or a uric acid-related disease, the composition containing the compound of chemical formula I at a dose of more than 2 mg and equal to or less than 10 mg and being orally administered once a day; and a hydrochloride 1.5 hydrate of the novel compound of chemical formula I.
